Search | TVST | ARVO Journals

tvst

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (12)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (13)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (12)
Clinical Trials (1)
Review (1)

Topics

Eye Anatomy and Disorders (2)
Glaucoma (2)
Translational Research (1)

Tags

intraocular pressure (2)
donors (1)
eye (1)
glaucoma (1)
nitric oxide (1)
ocular hypertension (1)
open-angle glaucoma (1)
placebos (1)
safety (1)

Specify Date Range

From: To: Apply

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Effects of perfluorohexyloctane on the ocular pharmacokinetics of latanoprost and prednisolone acetate after topical administration to rabbits

Megan Cavet; Shellise Glogowski; Jason L Vittitow; Christopher E. Starr; Melissa Barnett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5776.

ARVO Annual Meeting Abstract June 2024

Efficacy of perfluorohexyloctane ophthalmic solution in patients with dry eye disease stratified by baseline severity

John Sheppard; Jason L Vittitow; Megan Cavet; Gregory Katz; Doug Devries; Darrell E. White

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2966.

ARVO Annual Meeting Abstract June 2024

Preclinical Toxicity Profile of Perfluorohexyloctane Ophthalmic Solution

Jason L Vittitow; Johannes Korward; Weston Pack; Justin Schweitzer; Alice T. Epitropoulos

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3587.

ARVO Annual Meeting Abstract July 2018

Plasma Pharmacokinetics and Safety following Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025% in Healthy Adults

Lester O Hosten; Jason L Vittitow

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):140.

ARVO Annual Meeting Abstract July 2018

Safety and efficacy of a novel submicron loteprednol etabonate gel in the treatment of inflammation and pain post-cataract surgery

Jason L Vittitow; Thomas LoBue; Joseph Martel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2235.

ARVO Annual Meeting Abstract July 2018

Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation post-cataract surgery in children

Bibiana Jin Jin Reiser; Jon I Williams; Jason L Vittitow

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2666.

ARVO Annual Meeting Abstract September 2016

Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

James H Peace; Felipe A Medeiros; Keith R Martin; Jason L Vittitow; Robert N Weinreb

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3035.

ARVO Annual Meeting Abstract September 2016

Integrated Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies

Paul L Kaufman; Jeffrey M Liebmann; Jason L Vittitow; Robert N Weinreb

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3036.

ARVO Annual Meeting Abstract September 2016

Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study

Kazuhide Kawase; Jason L Vittitow; Tetsuya Yamamoto; Makoto Araie

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3037.

ARVO Annual Meeting Abstract September 2016

Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies

Jason L Vittitow; Jeffrey M Liebmann; Paul L Kaufman; Felipe A Medeiros; Keith R Martin; Robert N Weinreb

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3030.

Clinical Trials September 2014

Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma

PDF

Carol A. Rasmussen; Paul L. Kaufman; Robert Ritch; Reza Haque; R. Kim Brazzell; Jason L. Vittitow
TAGS: intraocular pressure, ocular hypertension, open-angle glaucoma, placebos, safety, eye
Trans. Vis. Sci. Tech.. 2014; 3(5):1. https://doi.org/10.1167/tvst.3.5.1

Review August 2014

Nitric Oxide (NO): An Emerging Target for the Treatment of Glaucoma

PDF

Megan E. Cavet; Jason L. Vittitow; Francesco Impagnatiello; Ennio Ongini; Elena Bastia
TAGS: donors, glaucoma, intraocular pressure, nitric oxide
Invest. Ophthalmol. Vis. Sci.. 2014; 55(8):5005-5015. https://doi.org/10.1167/iovs.14-14515

ARVO Annual Meeting Abstract April 2014

Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Lowering IOP over 24 hours in Subjects With Open Angle Glaucoma or Ocular Hypertension (CONSTELLATION)

John H K Liu; Jason L Vittitow; Quintus Ngumah; Robert N Weinreb

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3549.

ARVO Annual Meeting Abstract April 2014

Efficacy of Latanoprostene Bunod Ophthalmic Solution, 0.024%, in Lowering Intraocular Pressure Over 24-Hours in Normal Japanese Subjects (KRONUS)

Makoto Araie; Tuyen Ong; Baldo Scassellati-Sforzolini; Quintus Ngumah; Jason L Vittitow; Robert N Weinreb

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):548.

« Previous

Advertisement

Follow @ARVOtvst

TVST Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 2164-2591

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2024 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept